Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?- Well known Tea Brands for Each Tea Sweetheart
- Terminal cancer diagnosis announced by JFK's granddaughter
- L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- How did this 20-light-year-wide 'Diamond Ring' form in space? Maybe a cosmic bubble burst
- What to know as New York City nurses strike for a 3rd day
- Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- The 15 Most Motivating TED Discusses All Time
